Successful use of rituximab in refractory cardiac sarcoidosis

Rheumatology (Oxford). 2016 Jan;55(1):189-91. doi: 10.1093/rheumatology/kev309. Epub 2015 Sep 13.

Authors

Megan L Krause¹, Leslie T Cooper², Panithaya Chareonthaitawee³, Shreyasee Amin⁴

Affiliations

¹ Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN.
² Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL.
³ Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN and.
⁴ Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA amin.shreyasee@mayo.edu.

PMID: 26370399
DOI: 10.1093/rheumatology/kev309

No abstract available

Publication types

Letter

MeSH terms

Cardiomyopathies / drug therapy*
Female
Humans
Immunologic Factors / therapeutic use
Middle Aged
Rituximab / therapeutic use*
Sarcoidosis / drug therapy*

Substances

Immunologic Factors
Rituximab